Nobex Corporation Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $5M

Nobex Corporation General Information

Description

Developer of an oral insulin product for diabetes. The company offers Oratonin, an oral modified salmon calcitonin with antibone-resorptive and analgesic properties for bone disorders; APAZA compound, an oral tablet for inflammatory bowel disease and insulin in an oral tablet for diabetes.

Contact Information

Formerly Known As
Protein Delivery
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 617 Davis Drive
  • Suite 100
  • Morrisville, NC 27709
  • United States
+1 (919)
Primary Industry
Pharmaceuticals
Acquirer
Corporate Office
  • 617 Davis Drive
  • Suite 100
  • Morrisville, NC 27709
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nobex Corporation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 28-Mar-2006 $5M Completed Generating Revenue
8. Bankruptcy: Admin/Reorg 01-Dec-2005 Completed Generating Revenue
7. Later Stage VC 14-May-2003 Completed Generating Revenue
6. Later Stage VC (Series F) 14-Aug-2002 Completed Generating Revenue
5. Later Stage VC (Series E) 03-Jun-1999 Completed Product Development
4. Debt - General 05-Jun-1996 Completed
3. Later Stage VC (Series C) 23-Nov-1994 Completed Product Development
2. Early Stage VC (Series A) 03-Jun-1994 $1.4M Completed Product Development
1. Early Stage VC (Series B) 01-Apr-1994 $1.4M $1.4M Completed Product Development
To view Nobex Corporation’s complete valuation and funding history, request access »

Nobex Corporation Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 1,187,049 $0.010000 $1.39 $1.39 $1.39 2.55%
Series A 3,931,909 $0.010000 $2 $1.39 $2 8.46%
To view Nobex Corporation’s complete cap table history, request access »

Nobex Corporation Patents

Nobex Corporation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8314214-B2 Synthesis of azo bonded immunoregulatory compounds Inactive 07-Jul-2004
US-20110201792-A1 Synthesis of azo bonded immunoregulatory compounds Active 07-Jul-2004
US-20130096286-A1 Synthesis of azo bonded immunoregulatory compounds Active 07-Jul-2004
US-8754197-B2 Synthesis of azo bonded immunoregulatory compounds Active 07-Jul-2004
US-20090281023-A9 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment Inactive 24-Jun-2003 A61K38/23
To view Nobex Corporation’s complete patent history, request access »

Nobex Corporation Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
AEA Investors PE/Buyout Minority
American Express Corporation Minority
Crescendo Ventures Venture Capital Minority
Endpoint Late Stage Fund Venture Capital Minority
HealthCap Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Nobex Corporation FAQs

  • When was Nobex Corporation founded?

    Nobex Corporation was founded in 1993.

  • Where is Nobex Corporation headquartered?

    Nobex Corporation is headquartered in Morrisville, NC.

  • What industry is Nobex Corporation in?

    Nobex Corporation’s primary industry is Pharmaceuticals.

  • Is Nobex Corporation a private or public company?

    Nobex Corporation is a Private company.

  • What is the current valuation of Nobex Corporation?

    The current valuation of Nobex Corporation is .

  • What is Nobex Corporation’s current revenue?

    The current revenue for Nobex Corporation is .

  • How much funding has Nobex Corporation raised over time?

    Nobex Corporation has raised $69.6M.

  • Who are Nobex Corporation’s investors?

    AEA Investors, American Express, Crescendo Ventures, Endpoint Late Stage Fund, and HealthCap are 5 of 10 investors who have invested in Nobex Corporation.

  • When was Nobex Corporation acquired?

    Nobex Corporation was acquired on 28-Mar-2006.

  • Who acquired Nobex Corporation?

    Nobex Corporation was acquired by Biocon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »